ESC Congress 2018

25 - 29 August 2018, Munich - Germany

Session Details

Clinical Trial Updates
Sun 26 Aug 11:00 - 12:30 Other Late-Breaking Science Brahms - The Hub
Chairpersons: Michel KOMAJDA (Paris, France), David HASDAI (Petah-Tikva, Israel)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
11:001321COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with RivaroxabanJohn William EIKELBOOM (Hamilton, Canada)
11:101322Discussant review - COMPASS.Lars WALLENTIN (Uppsala, Sweden)
11:151323CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and MortalityPaul M RIDKER (Boston, United States of America)
11:251324Discussant review - CANTOS.Milton PACKER (Dallas, United States of America)
11:301325CABANA Trial - Recurrence of Atrial Arrhythmias in the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial FibrillationJeanne POOLE (Seattle, United States of America)
11:401326Discussant review - CABANA.Christophe LECLERCQ (Rennes, France)
11:451327ASCOT Legacy study - Longterm impact of the of BP and Lipid lowering treatment in hypertensive patientsAjay GUPTA (London, United Kingdom)
11:551328Discussant review - ASCOT.Diederick E GROBBEE (Utrecht, Netherlands)
12:001329ASCT-1 - 15-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis: extended post-trial follow-up of patients in the first Asymptomatic Carotid Surgery Trial Richard BULBULIA (Oxford, United Kingdom)
12:101330Discussant review - ACST-1.Marco ROFFI (Geneva, Switzerland)
12:151331TRICS III - Restrictive versus liberal red blood cell transfusion in cardiac surgery: 6 month dataC David MAZER (Toronto, Canada)
12:251332Discussant review - TRICS-III.Miguel SOUSA UVA (Lisbon, Portugal)